Hospitalization for Invasive Pneumococcal Diseases in Young Children before Use of 13-Valent Pneumococcal Conjugate Vaccine, Suzhou, China
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Hospitalization for Invasive Pneumococcal Diseases in Young Children before Use of 13-Valent Pneumococcal Conjugate Vaccine, Suzhou, China
  • Published Date:

    Jan 2021

  • Source:
    Emerg Infect Dis. 27(1):69-75
  • Language:
    English
Filetype[PDF-1.25 MB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 607.04 KB]
    Personal Author:
    Chiba, Naoko; Morozumi, Miyuki; Shouji, Michi; Wajima, Takeaki; Iwata, Satoshi; Ubukata, Kimiko;
    Corporate Authors:
    Invasive Pneumococcal Diseases Surveillance Study Group
    Published Date:
    Jul 2014
    Source:
    Emerg Infect Dis. 20(7):1132-1139.
    Description:
    We aimed to clarify changes in serotypes and genotypes mediating β-lactam and macrolide resistance in Streptococcus pneumoniae isolates from Japanese children who had invasive pneumococcal disease (IPD) after the 7-valent pneumococcal conjugate vacc...
    File Type:
    Filetype[PDF - 607.04 KB]
  2. Filetype[PDF - 2.43 MB]
    Personal Author:
    Oligbu, Godwin; Collins, Sarah; Djennad, Abdelmajid; Sheppard, Carmen L.; Fry, Norman K.; Andrews, Nick J.; Borrow, Ray; Ramsay, Mary E.; Ladhani, Shamez N.;
    Published Date:
    Sep 2019
    Source:
    Emerg Infect Dis. 25(9):1708-1718
    Description:
    We describe the effects of the 7-valent (PCV7) and 13-valent (PCV13) pneumococcal conjugate vaccines on pneumococcal meningitis in England and Wales during July 1, 2000-June 30, 2016. Overall, 84,473 laboratory-confirmed invasive pneumococcal disease...
    File Type:
    Filetype[PDF - 2.43 MB]
  3. Filetype[PDF - 1.12 MB]
    Personal Author:
    Regev-Yochay, Gili; Reisenberg, Klaris; Katzir, Michal; Wiener-Well, Yonit; Rahav, Galia; Strahilevitz, Jacob; Istomin, Valery; Tsyba, Evgenia; Peretz, Avi; Khakshoor, Shirley; Dagan, Ron;
    Corporate Authors:
    on behalf of the Israeli Adult Invasive Pneumococcal Disease Group
    Published Date:
    Jul 2018
    Source:
    Emerg Infect Dis. 24(7):1275-1284.
    Description:
    The indirect effect of pneumococcal conjugate vaccine on adult pneumococcal meningitis has not been thoroughly investigated. We present data from active surveillance on pneumococcal meningitis in adults in Israel occurring during July 2009-June 2015....
    File Type:
    Filetype[PDF - 1.12 MB]
  4. Filetype[PDF - 2.60 MB]
    Personal Author:
    Houseman, Catherine; Hughes, Gareth J.; Chapman, Kaye E.; Wilson, Deborah; Gorton, Russell;
    Published Date:
    Jan 2017
    Source:
    Emerg Infect Dis. 23(1):122-126.
    Description:
    Since April 2014, invasive pneumococcal disease incidence has increased substantially across North East England, United Kingdom, reversing the decline that followed the 2006 introduction of pneumococcal conjugate vaccines. Significant increases occur...
    File Type:
    Filetype[PDF - 2.60 MB]
  5. Filetype[PDF - 1.32 MB]
    Personal Author:
    Ubukata, Kimiko; Chiba, Naoko; Hanada, Shigeo; Morozumi, Miyuki; Wajima, Takeaki; Shouji, Michi; Iwata, Satoshi;
    Corporate Authors:
    Invasive Pneumococcal Diseases Surveillance Study Group
    Published Date:
    Nov 2015
    Source:
    Emerg Infect Dis. 21(11):1956-1965
    Description:
    After 7-valent pneumococcal conjugate vaccine (PCV) for children was introduced in Japan in November 2010, we examined changes in Streptococcus pneumoniae serotypes and in genetic antimicrobial drug resistance of isolates from adults with invasive pn...
    File Type:
    Filetype[PDF - 1.32 MB]